247 related articles for article (PubMed ID: 34865653)
1. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
Yan G; Li D; Lin Y; Fu Z; Qi H; Liu X; Zhang J; Si S; Chen Y
Cell Biosci; 2021 Dec; 11(1):199. PubMed ID: 34865653
[TBL] [Abstract][Full Text] [Related]
2. [Identifying SARS-CoV-2 main protease inhibitors by a novel sandwich-like fluorescence polarization screening assay].
Yan H; Yan G; Qi H; Liu Z; Liu X; Liu X; Li N; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2352-2364. PubMed ID: 35786485
[TBL] [Abstract][Full Text] [Related]
3. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
4. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
5. [Discovery of SARS-CoV-2 main protease inhibitors using an optimized FRET-based high-throughput screening assay].
Yan G; Li D; Qi H; Fu Z; Liu X; Zhang J; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2236-2249. PubMed ID: 35786475
[TBL] [Abstract][Full Text] [Related]
6. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors.
Yan H; Liu Z; Yan G; Liu X; Liu X; Wang Y; Chen Y
Virology; 2022 Sep; 574():18-24. PubMed ID: 35870326
[TBL] [Abstract][Full Text] [Related]
7. Biochemical screening for SARS-CoV-2 main protease inhibitors.
Coelho C; Gallo G; Campos CB; Hardy L; Würtele M
PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015
[TBL] [Abstract][Full Text] [Related]
8. Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease.
Li D; Yan G; Zhou W; Si S; Liu X; Zhang J; Li Y; Chen Y
Cell Biosci; 2022 May; 12(1):65. PubMed ID: 35590420
[TBL] [Abstract][Full Text] [Related]
9. Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay.
Zhang J; Yan H; Yan G; Liu X; Wang Y; Chen Y
STAR Protoc; 2022 Dec; 3(4):101794. PubMed ID: 36317181
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
[TBL] [Abstract][Full Text] [Related]
12. Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2.
Zhang W; Lin SX
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851795
[TBL] [Abstract][Full Text] [Related]
13. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.
Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA
J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661
[TBL] [Abstract][Full Text] [Related]
14. Identification of alkaloids from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380
[TBL] [Abstract][Full Text] [Related]
15. Identification of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
18. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
Huynh T; Wang H; Luan B
Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
[TBL] [Abstract][Full Text] [Related]
19. Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
Park JY; Kim JH; Kwon JM; Kwon HJ; Jeong HJ; Kim YM; Kim D; Lee WS; Ryu YB
Bioorg Med Chem; 2013 Jul; 21(13):3730-7. PubMed ID: 23647823
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of expression conditions and determination the proteolytic activity of codon-optimized SARS-CoV-2 main protease in Escherichia coli].
Chen Y; Fu Z; Yan G; Lin Y; Liu X
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1334-1345. PubMed ID: 33973446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
